Clinical Implications of Pharmacogenetic Variation on the Effects of Statins

By Maggo Simran D.S.  

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 1-19

Adis International

Access to resources Recommend Favorite

Microbial Efflux Pump Inhibition: Tactics and Strategies

By  

Current Pharmaceutical Design, Vol. 17, Iss. 13, 2011-05 ,pp. : 1291-1302

Bentham Science Publishers

Access to resources Recommend Favorite

Fluoroquinolones in Paediatrics

By Gendrel D.   Moulin F.  

Pediatric Drugs, Vol. 3, Iss. 5, 2001-01 ,pp. : 365-377

Adis International

Access to resources Recommend Favorite

Genetic Analysis of CYP2D6 Polymorphism in Indian Populations and its Pharmacogenetic Implications

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 2, 2014-06 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications

By Suarez-Kurtz Guilherme   Amorim António   Damasceno Albertino   Hutz Mara H   Moraes Manuel Odorico de   Ojopi Élida B   Pena Sérgio DJ   Perini Jamila A   Prata Maria João   Ribeiro-dos-Santos Ândrea   Romano-Silva Marco A   Teixeira Daniel   Struchiner Claudio José  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1257-1267

Future Medicine

Access to resources Recommend Favorite